0%) ( Perspectives and conclusions Tirzepatide has demonstrated marked and dose-dependent reductions in glycemic parameters in patients with T2D that, according to the present study data, surpass the effects of the GLP-1RA dulaglutide and semaglutide (66, 67, 71)
B., Latif, R., Alqoofi, J
Li B, Bedard K, Sorce S, Hinz B, Dubois-Dauphin M, Krause KH
Wijma RA, Fransen F, Muller AE, Mouton JW
Covert HE, which encompasses MHE (detectable only through altered neuropsychometric tests that are described in these guidelines further ahead) plus grade I HE, is typically associated with frequent falls, altered motor skills (e.g., in driving), the presence of fatigue, disinterest, distraction with fluctuating attention span and response inhibition
Pharmacotherapeutics for Advanced Practice: A Practical Approach